AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23482466 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal deformation amplitude (CDA)
Number of subjects: 180
Study 23482466 — intervention group
Group type: EXPERIMENTAL
Intervention: Difference between DCT and GAT measurements
Number of subjects: 180
Study 23482466 — intervention group
Group type: EXPERIMENTAL
Intervention: IOP difference
Number of subjects: 180
Study 21795446 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorcaserin 10 mg BID
Number of subjects: 4008
Study 21795446 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorcaserin 10 mg QD
Number of subjects: 4008
Study 21795446 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4008
Study 21795446 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorcaserin 10 mg BID and QD
Number of subjects: 4008
Study 18800005 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation
Number of subjects: 188
Study 18800005 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 188
Study 16255390 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cue-exposure program to drug-related stimuli (12 treatment sessions, 3 times weekly)
Number of subjects: 24
Study 16255390 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study 12408216 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic touch (5 to 7 minutes, 2 times a day for 3 days)
Number of subjects: 10
Study 12408216 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic touch
Number of subjects: 10
Study 9935221 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radio‐chemo‐thermo‐therapy (RCTT)
Number of subjects: 27
Study 9935221 — intervention group
Group type: COMPARATOR
Intervention: Radio‐chemo‐therapy (RCT) without hyperthermia (control group)
Number of subjects: 27
Study 7778631 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocolysis (intravenous magnesium sulfate and/or oral or subcutaneous beta-sympathomimetics)
Number of subjects: 112
Study 7778631 — intervention group
Group type: COMPARATOR
Intervention: Short-term intravenous magnesium alone
Number of subjects: 112
Study 7778631 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocolysis
Number of subjects: 112
Study 2368684 — intervention group
Group type: EXPERIMENTAL
Intervention: Ward ambulation program
Number of subjects: 51
Study 2368684 — intervention group
Group type: EXPERIMENTAL
Intervention: Dedicated exercise center program
Number of subjects: 51
Study 6985697 — intervention group
Group type: EXPERIMENTAL
Intervention: Molsidomine (0.03 mg/kg IV) during exercise-induced angina
Number of subjects: 14
Study 6985697 — intervention group
Group type: EXPERIMENTAL
Intervention: Molsidomine (0.03 mg/kg IV) during pacing-induced angina
Number of subjects: 14
Study 6985697 — intervention group
Group type: COMPARATOR
Intervention: Molsidomine (2 mg three times daily)
Number of subjects: 14
Study 31221197 — intervention group
Group type: EXPERIMENTAL
Intervention: ML-Adaptive Boosting
Number of subjects: 3624
Study 31221197 — intervention group
Group type: EXPERIMENTAL
Intervention: ML-random forest
Number of subjects: 3624
Study 31221197 — intervention group
Group type: COMPARATOR
Intervention: BCRAT
Number of subjects: 3624
Study 31221197 — intervention group
Group type: EXPERIMENTAL
Intervention: ML-adaptive boosting
Number of subjects: 3624
Study 31221197 — intervention group
Group type: EXPERIMENTAL
Intervention: ML-Markov chain Monte Carlo generalized linear mixed model
Number of subjects: 3624
Study 31221197 — intervention group
Group type: COMPARATOR
Intervention: BOADICEA
Number of subjects: 3624
Study 27928843 — intervention group
Group type: EXPERIMENTAL
Intervention: SIRS after cardiac surgery with cardiopulmonary bypass (CPB)
Number of subjects: 116
Study 27928843 — intervention group
Group type: EXPERIMENTAL
Intervention: SIRS after cardiac surgery without cardiopulmonary bypass (CPB)
Number of subjects: 116
Study 27928843 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of CPB
Number of subjects: 116
Study 27928843 — intervention group
Group type: EXPERIMENTAL
Intervention: Amount of fresh frozen plasma
Number of subjects: 116
Study 27928843 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonates
Number of subjects: 116
Study 27928843 — intervention group
Group type: EXPERIMENTAL
Intervention: SIRS
Number of subjects: 116
Study 26433456 — intervention group
Group type: EXPERIMENTAL
Intervention: GMT 2.0 treatment
Number of subjects: 55
Study 26433456 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 55
Study 23611375 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:100,000 epinephrine buffered with 5% sodium bicarbonate
Number of subjects: 30
Study 23611375 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:100,000 epinephrine buffered with 10% sodium bicarbonate
Number of subjects: 30
Study 23611375 — intervention group
Group type: COMPARATOR
Intervention: 2% lidocaine with 1:100,000 epinephrine (nonbuffered)
Number of subjects: 30
Study 21654441 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet counseling
Number of subjects: 1386
Study 21654441 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone counseling
Number of subjects: 1386
Study 21654441 — intervention group
Group type: COMPARATOR
Intervention: Control (self-directed materials)
Number of subjects: 1386
Study 19117888 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly parenting newsletter (12 issues) containing information on emotional development, parent-child interaction, and play.
Number of subjects: 185
Study 19117888 — intervention group
Group type: COMPARATOR
Intervention: Normal parenting support (received by both groups).
Number of subjects: 185
Study 16434455 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 1162
Study 16434455 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 1162
Study 16009958 — intervention group
Group type: COMPARATOR
Intervention: Preoperative radiotherapy (preop RT) 45 Gy in 5 weeks
Number of subjects: 1011
Study 16009958 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy plus two 5-day chemotherapy courses (fluorouracil 350 mg/m2/d and leucovorin 20 mg/m2/d) in the first and fifth week of RT
Number of subjects: 1011
Study 16009958 — intervention group
Group type: COMPARATOR
Intervention: Preoperative radiotherapy plus four postoperative chemotherapy courses
Number of subjects: 1011
Study 16009958 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy and chemotherapy plus postoperative chemotherapy
Number of subjects: 1011
Study 11888223 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis (standardized eight-session hypnosis treatment)
Number of subjects: 0
Study 11888223 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation (standardized eight sessions of Jacobson's relaxation treatment)
Number of subjects: 0
Study 11888223 — intervention group
Group type: COMPARATOR
Intervention: Control (waiting list)
Number of subjects: 0
Study 10455902 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based training (CBT)
Number of subjects: 69
Study 10455902 — intervention group
Group type: COMPARATOR
Intervention: Didactic training
Number of subjects: 69
Study 10455902 — intervention group
Group type: COMPARATOR
Intervention: Videotape training
Number of subjects: 69
Study 8778010 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal color Doppler ultrasonography in patients with cervix carcinoma
Number of subjects: 0
Study 8778010 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 0
Study 2085082 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol alone (12‐15 mg/kg/h)
Number of subjects: 20
Study 2085082 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol with fentanyl supplementation (6‐9 mg/kg/h)
Number of subjects: 20
Study 380268 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 50
Study 380268 — intervention group
Group type: COMPARATOR
Intervention: Chlorpromazine
Number of subjects: 50
Study 31694394 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically determined levels of HDL-C
Number of subjects: 407558
Study 31694394 — intervention group
Group type: EXPERIMENTAL
Intervention: HDL-C polygenic score
Number of subjects: 407558
Study 31694394 — intervention group
Group type: COMPARATOR
Intervention: LDL-C and triglyceride polygenic scores
Number of subjects: 407558
Study 30945124 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease-modifying anti-rheumatic drugs (DMARDs)
Number of subjects: 20707
Study 30945124 — intervention group
Group type: COMPARATOR
Intervention: Non-DMARD users (Control)
Number of subjects: 20707
Study 27182679 — intervention group
Group type: EXPERIMENTAL
Intervention: HFR (Hemodiafiltration with endogenous reinfusion)
Number of subjects: 17
Study 27182679 — intervention group
Group type: COMPARATOR
Intervention: OLHDF (Online-hemodiafiltration)
Number of subjects: 17
Study 24696369 — intervention group
Group type: EXPERIMENTAL
Intervention: Stop-smoking medication
Number of subjects: 1319
Study 24696369 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy (preferred by 85.2% of medication users)
Number of subjects: 1319
Study 24696369 — intervention group
Group type: COMPARATOR
Intervention: Modern smoking cessation group programme
Number of subjects: 1319
Study 23643001 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid 10 mg/kg (intravenous injection slowly before skin incision) followed by infusion of normal saline until postoperative 12 hours
Number of subjects: 60
Study 23643001 — intervention group
Group type: COMPARATOR
Intervention: Tranexamic acid 10 mg/kg (intravenous injection slowly before skin incision) followed by infusion of tranexamic acid 1 mg/(kg·h) until postoperative 12 hours
Number of subjects: 60
Study 21134507 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive method change during the trial
Number of subjects: 122
Study 21134507 — intervention group
Group type: EXPERIMENTAL
Intervention: Participant desire/partners' desire for future children
Number of subjects: 122
Study 21134507 — intervention group
Group type: EXPERIMENTAL
Intervention: Age of participants
Number of subjects: 122
Study 19998582 — intervention group
Group type: EXPERIMENTAL
Intervention: Test drug (Acnez)
Number of subjects: 12
Study 19998582 — intervention group
Group type: COMPARATOR
Intervention: Reference drug
Number of subjects: 12
Study 17465647 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticotomy-assisted technique
Number of subjects: 6
Study 17465647 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgical technique
Number of subjects: 6
Study 15140569 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye movement desensitization and reprocessing method (EMDR)
Number of subjects: 10
Study 15140569 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (Control)
Number of subjects: 10
Study 15140569 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychometric assessment after EMDR treatment
Number of subjects: 10
Study 11796084 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of albendazole (400 mg) and praziquantel (40 mg/kg)
Number of subjects: 268
Study 11796084 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 268
Study 9494455 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics plus intranasal beclomethasone (336 micrograms/day)
Number of subjects: 61
Study 9494455 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic antibiotics
Number of subjects: 61
Study 9494455 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic antibiotics plus intranasal placebo
Number of subjects: 61
Study 7766965 — intervention group
Group type: EXPERIMENTAL
Intervention: A new amino acid mixture incorporated into medical foods
Number of subjects: 0
Study 7766965 — intervention group
Group type: EXPERIMENTAL
Intervention: Occult monitoring of medical foods purchased
Number of subjects: 0
Study 10303911 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass mammography screening (specific details on dosage and duration not available)
Number of subjects: 0
Study 30316742 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 28
Study 30316742 — intervention group
Group type: COMPARATOR
Intervention: Control (sham tDCS)
Number of subjects: 28
Study 29630787 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.454% stannous fluoride dentifrice (1,100 ppm fluoride)
Number of subjects: 35
Study 29630787 — intervention group
Group type: COMPARATOR
Intervention: 1.5% arginine-containing dentifrice (Colgate Maximum Cavity Protection, 1,450 ppm fluoride)
Number of subjects: 35
Study 27621414 — intervention group
Group type: EXPERIMENTAL
Intervention: Cups
Number of subjects: 2110
Study 27621414 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaspoon‐only label with milliliter and teaspoon tool
Number of subjects: 2110
Study 27621414 — intervention group
Group type: EXPERIMENTAL
Intervention: Syringes (0.2‐ and 0.5‐mL increments)
Number of subjects: 2110
Study 27621414 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall dosing error
Number of subjects: 2110
Study 25558545 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric pressure at 607.95 kPa (6 atm abs)
Number of subjects: 139
Study 25558545 — intervention group
Group type: COMPARATOR
Intervention: Surface learning (101.325 kPa, 1 atm abs)
Number of subjects: 139
Study 25558545 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological and biographical factors
Number of subjects: 139
Study 22122880 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapering of daytime benzodiazepines
Number of subjects: 30
Study 20178935 — intervention group
Group type: EXPERIMENTAL
Intervention: A priori liking manipulation
Number of subjects: 0
Study 20178935 — intervention group
Group type: COMPARATOR
Intervention: Disliking a target
Number of subjects: 0
Study 17275507 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab
Number of subjects: 25
Study 17275507 — intervention group
Group type: COMPARATOR
Intervention: Antithymocyte globulin (ATG)
Number of subjects: 25
Study 15611002 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based awareness program
Number of subjects: 271
Study 15611002 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 271
Study 12435975 — intervention group
Group type: EXPERIMENTAL
Intervention: Side‐posture spinal adjusting (manipulation)
Number of subjects: 64
Study 12435975 — intervention group
Group type: EXPERIMENTAL
Intervention: Side‐posture positioning
Number of subjects: 64
Study 12435975 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 64
Study 9932687 — intervention group
Group type: EXPERIMENTAL
Intervention: New ATLS course (1997)
Number of subjects: 32
Study 9932687 — intervention group
Group type: COMPARATOR
Intervention: Old ATLS course (1993)
Number of subjects: 32
Study 7586343 — intervention group
Group type: COMPARATOR
Intervention: Systolic Blood Pressure (SBP) < 140 mm Hg
Number of subjects: 5362
Study 7586343 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP) >= 140 mm Hg
Number of subjects: 5362
Study 7586343 — intervention group
Group type: COMPARATOR
Intervention: Diastolic Blood Pressure (DBP) < 70 mm Hg
Number of subjects: 5362
Study 7586343 — intervention group
Group type: COMPARATOR
Intervention: Diastolic Blood Pressure (DBP) 70 to 79 mm Hg
Number of subjects: 5362
Study 7586343 — intervention group
Group type: COMPARATOR
Intervention: Diastolic Blood Pressure (DBP) 80 to 89 mm Hg
Number of subjects: 5362
Study 7586343 — intervention group
Group type: COMPARATOR
Intervention: Diastolic Blood Pressure (DBP) 90 to 99 mm Hg
Number of subjects: 5362
Study 7586343 — intervention group
Group type: COMPARATOR
Intervention: Diastolic Blood Pressure (DBP) >= 100 mm Hg
Number of subjects: 5362
Study 7586343 — intervention group
Group type: EXPERIMENTAL
Intervention: SBP >= 140 mm Hg
Number of subjects: 5362
Study 2408233 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromium picolinate (3.8 micromol [200 micrograms] chromium)
Number of subjects: 28
Study 2408233 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 43682 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg
Number of subjects: 219
Study 43682 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 1 mg
Number of subjects: 219
Study 43682 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study 43682 — intervention group
Group type: COMPARATOR
Intervention: 90% Alcohol (10-6 ml)
Number of subjects: 219
Study 43682 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam and Lorazepam
Number of subjects: 219
Study 43682 — intervention group
Group type: COMPARATOR
Intervention: Placebo, Alcohol, and Diazepam
Number of subjects: 219
Study 31388104 — intervention group
Group type: EXPERIMENTAL
Intervention: MDD participants (N=106)
Number of subjects: 164
Study 31388104 — intervention group
Group type: EXPERIMENTAL
Intervention: MDD participants (N=58)
Number of subjects: 164
Study 31388104 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (N=36)
Number of subjects: 164
Study 31388104 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (N=58)
Number of subjects: 164
Study 31388104 — intervention group
Group type: EXPERIMENTAL
Intervention: MDD participants
Number of subjects: 164
Study 30838448 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning (RIPC)
Number of subjects: 206
Study 30838448 — intervention group
Group type: COMPARATOR
Intervention: Control (no RIPC)
Number of subjects: 206
Study 29024325 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg p-synephrine
Number of subjects: 17
Study 29024325 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/kg p-synephrine
Number of subjects: 17
Study 29024325 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg/kg p-synephrine
Number of subjects: 17
Study 29024325 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 26749578 — intervention group
Group type: EXPERIMENTAL
Intervention: PATHS to PAX (integrated program of PAX GBG and PATHS)
Number of subjects: 350
Study 26749578 — intervention group
Group type: EXPERIMENTAL
Intervention: PAX Good Behavior Game (PAX GBG)
Number of subjects: 350
Study 26749578 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 350
Study 24585500 — intervention group
Group type: EXPERIMENTAL
Intervention: Group mindfulness meditation for 6 weeks
Number of subjects: 170
Study 24585500 — intervention group
Group type: COMPARATOR
Intervention: Individual mindfulness meditation for 6 weeks
Number of subjects: 170
Study 22349568 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic partial nephrectomy (LPN) with warm ischemia
Number of subjects: 54
Study 20809735 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable cages (70/30 poly(l‐lactide‐co‐d,l‐lactide) (PLDLA))
Number of subjects: 81
Study 20809735 — intervention group
Group type: COMPARATOR
Intervention: Carbon fiber cages
Number of subjects: 81
Study 18084799 — intervention group
Group type: EXPERIMENTAL
Intervention: Unifocal pacing (UP)
Number of subjects: 19
Study 18084799 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifocal pacing (BP)
Number of subjects: 19
Study 18084799 — intervention group
Group type: COMPARATOR
Intervention: Back-up pacing
Number of subjects: 19
Study 18084799 — intervention group
Group type: EXPERIMENTAL
Intervention: Overdrive pacing
Number of subjects: 19
Study 15585598 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine infusion (Epi) during hyperinsulinemic euglycemic clamp studies
Number of subjects: 34
Study 15585598 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine infusion (Epi)
Number of subjects: 34
Study 12198053 — intervention group
Group type: EXPERIMENTAL
Intervention: Acoustic reflectometry
Number of subjects: 0
Study 10996882 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment plus group therapy (TG+)
Number of subjects: 88
Study 10996882 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone (TG-)
Number of subjects: 88
Study 8629922 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus intrathecal injection of 50 micrograms baclofen
Number of subjects: 11
Study 8629922 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 11
Study 1309633 — intervention group
Group type: EXPERIMENTAL
Intervention: PI regimen (cisplatin 80 mg/m2 dl and ifosfamide 2 g/m2 d 1, 2, 3, q 3‐4 wks)
Number of subjects: 83
Study 1309633 — intervention group
Group type: COMPARATOR
Intervention: PV regimen (cisplatin 80 mg/m2 d 1 and vindesine 3 mg/m2 d 1, 8, 15, q 3‐4 wks)
Number of subjects: 83
Study 6152804 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg megestrol acetate and 5 mg estradiol valerate
Number of subjects: 828
Study 6152804 — intervention group
Group type: EXPERIMENTAL
Intervention: Microencapsulated megestrol compound
Number of subjects: 828
Study 6152804 — intervention group
Group type: COMPARATOR
Intervention: Other three regimens (not specified)
Number of subjects: 828
Study 30213739 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-paced viewing of video tutorials
Number of subjects: 35
Study 30213739 — intervention group
Group type: COMPARATOR
Intervention: Group viewing of video tutorials
Number of subjects: 35
Study 30137497 — intervention group
Group type: EXPERIMENTAL
Intervention: The ABCDs of Pain Management video
Number of subjects: 128
Study 30137497 — intervention group
Group type: COMPARATOR
Intervention: Control video
Number of subjects: 128
Study 27394385 — intervention group
Group type: EXPERIMENTAL
Intervention: HIT intervention (multi-component approach including web-based provider training, multimedia electronic screening, risk assessment scores, clinical decision support)
Number of subjects: 0
Study 27394385 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 25046844 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic postconditioning (RIPostC)
Number of subjects: 78
Study 25046844 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 78
Study 21967563 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed situation (external store with explicit information on gains, losses, and probabilities)
Number of subjects: 0
Study 21967563 — intervention group
Group type: COMPARATOR
Intervention: Noninformed situation (age-adapted Iowa Gambling Task)
Number of subjects: 0
Study 20691834 — intervention group
Group type: EXPERIMENTAL
Intervention: n‐3 polyunsaturated fatty acids (1 g/d)
Number of subjects: 1229